Key Highlights
- Shares of Rocket Lab climbed 11.3%, reaching an intraday peak of $123.94 following Needham’s decision to increase its price target from $95 to $120 while maintaining a Buy rating.
- Cantor Fitzgerald elevated its price target to $96 from $85, highlighting improved launch performance and an expanding space services portfolio.
- First-quarter revenue totaled $200.35 million, representing 63.4% year-over-year growth and surpassing the consensus estimate of $189.65 million.
- Earnings per share aligned with forecasts at -$0.07, while management increased guidance for the second quarter.
- Wall Street’s consensus rating remains at “Moderate Buy” with an average analyst price target of $91.79.
Rocket Lab USA (RKLB) experienced a significant rally on Monday, advancing 11.3% after Needham & Company elevated its price target on the aerospace company from $95 to $120 while reaffirming its Buy rating.
The shares touched an intraday peak of $123.94 before closing near $117.35. Trading volume surged to approximately 53 million shares, exceeding the typical daily volume of 23.3 million by more than twofold.
The rally followed an impressive first-quarter earnings report. Rocket Lab delivered revenue of $200.35 million for Q1, surpassing the analyst consensus of $189.65 million while achieving 63.4% growth compared to the same period last year.
Earnings per share registered at -$0.07, matching Wall Street’s projections. The prior year figure stood at -$0.12 per share, demonstrating substantial progress in narrowing losses.
Management also elevated its Q2 guidance, further bolstering investor confidence in the stock.
Wall Street Firms Increase Their Targets
Cantor Fitzgerald added to the optimistic sentiment, lifting its price target to $96 from $85 while maintaining an Overweight rating. The firm highlighted Rocket Lab’s reliable launch operations and its varied service offerings, which span the Electron rocket, the Haste hypersonic test vehicle, and the forthcoming Neutron program.
Stifel Nicolaus maintained a Buy rating while raising its target to $105 from $90. Bank of America established a target of $120. Citigroup confirmed an Outperform rating on Friday.
The consensus average price target currently stands at $91.79, notably below the stock’s current trading level. This divergence illustrates the rapid upward movement in the share price.
Among analysts tracking RKLB, two maintain Strong Buy ratings, ten hold Buy ratings, four have assigned Hold ratings, and one carries a Sell rating.
First Quarter Performance Breakdown
Rocket Lab recorded a negative return on equity of 11.72% along with a net margin of -26.87%, typical metrics for a growth-phase aerospace enterprise.
The Q1 outperformance stemmed from robust activity across both launch services and spacecraft systems divisions. Cantor emphasized the company’s dual launch infrastructure spanning New Zealand and the United States as a competitive edge.
Rocket Lab maintains a market capitalization of approximately $66.82 billion, a debt-to-equity ratio of merely 0.02, and a current ratio of 4.47, indicating strong near-term financial flexibility.
The 50-day moving average rests at $72.88, while the 200-day moving average sits at $68.50, both substantially below present trading levels.
Insider activity has trended toward selling. Over the past 90 days, insiders disposed of approximately 233,449 shares valued at more than $16.4 million. SVP Arjun Kampani sold shares in early March at an average price of $69.59, while Director Merline Saintil sold at $75.04. Insider ownership currently represents roughly 8.4% of the company, with institutional investors controlling 71.78%.
Analyst projections anticipate full-year EPS of -$0.22 for the current fiscal year.
